Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)

VahatiCor's Coronary Sinus Reducer (A-FLUX) has been designed to improve angina or angina-like symptoms in patients with CMD. SERRA-I is an early feasibility study that evaluates the safety and clinical performance of the A-FLUX Reducer in this population.

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: VahatiCor, Inc.Updated: May 15, 2026Locations: 2
Eligibility criteria

Older than 18 years of age. [+8]

Significant obstructive epicardial disease (greater than 50% diameter stenosis)... [+18]

Read more
Status: Recruiting

Self-Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD) (SERRA-I Study)

VahatiCor's Coronary Sinus Reducer (A-FLUX) has been designed to improve angina or angina-like symptoms in patients with CMD. SERRA-I is an early feasibility study that evaluates the safety and clinical performance of the A-FLUX Reducer in this population.

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: VahatiCor, Inc.Updated: May 15, 2026Locations: 3
Eligibility criteria

Older than 18 years of age. [+8]

Significant obstructive epicardial disease (greater than 50% diameter stenosis)... [+18]

Read more